[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance Platform Technology Designation Program for Drug Development.[ Price : $8.95]
Federal Register notice: FDA decides to terminate the Science Advisory Board to the National Center for Toxicological Research bec...[ Price : $8.95]
Researchers at Yale and Emory say they find little evidence to support the notion that surrogate markers used in non-oncologic dru...[ Price : $8.95]
FDA approves Bristol Myers Squibbs Breyanzi (lisocabtagene maraleucel; liso-cel) for treating adult patients with relapsed or refr...[ Price : $8.95]
FDA accepts for priority review a Merck supplemental BLA for Keytruda (pembrolizumab) in combination with chemotherapy for the fir...[ Price : $8.95]
Attorney James Beck says the 5th Circuit Court of Appeals made defense-friendly decisions in reversing several errors made by a Lo...[ Price : $8.95]
FDA denies a 2019 Novartis petition asking for specific requirements for ANDA applicants citing Entresto as the reference-listed d...[ Price : $8.95]
OptumHealth Care Solutions recalls (Class 1) its Nimbus II Plus infusion pumps due to multiple potential failure modes that may in...